Are MAO-A deficiency states in the general population and in putative high-risk populations highly uncommon?

Journal of Neural Transmission, Supplement

Volumn , Issue 52, 1998, Pages 29-38

  Murphy, D L ^a   Sims, K ^b   Eisenhofer, G ^c   Greenberg, B D ^a   George, T ^d   Berlin, F ^e   Zametkin, A ^a   Ernst, M ^a   Breakefield, X O ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; AMINE OXIDASE (FLAVIN CONTAINING); ANTIDEPRESSANT AGENT; CLORGYLINE; ISOENZYME; MONOAMINE OXIDASE INHIBITOR; SELEGILINE;

ADULT; AGED; ARTICLE; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; DEAMINATION; DISEASE ASSOCIATION; ENZYME BINDING; ENZYME DEFICIENCY; GENE DELETION; GENE SEQUENCE; HIGH RISK POPULATION; HUMAN; MALE; NORRIE DISEASE; PHENOTYPE; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; TRANSGENIC MOUSE; ADOLESCENT; ANIMAL; ATTENTION DEFICIT DISORDER; BLOOD; CHROMOSOME MAP; DOMESTIC VIOLENCE; ENZYMOLOGY; GENETICS; MENTAL DISEASE; MIDDLE AGED; MOUSE; REFERENCE VALUE; RISK ASSESSMENT; SEXUAL CRIME; X CHROMOSOME;

ADOLESCENT; ADULT; AGED; ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHROMOSOME DELETION; CHROMOSOME MAPPING; DOMESTIC VIOLENCE; HUMANS; ISOENZYMES; MALE; MENTAL DISORDERS; METHOXYHYDROXYPHENYLGLYCOL; MICE; MICE, TRANSGENIC; MIDDLE AGED; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; REFERENCE VALUES; RISK ASSESSMENT; SELEGILINE; SEX OFFENSES; X CHROMOSOME;

EID: 0031596680     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6499-0_4     Document Type: Article

References (40)

1. Alm PO, af Klinteberg B, Humble K, Leppert J, Sorensen S, Thorell L-H, Lidberg L, Oreland L (1996) Psychopathy, platelet MAO activity and criminality among former juvenile delinquents. Acta Psychiatr Scand 94: 105-111
2. Berlin FS, Hunt WP, Malin HM, Dyer A, Lahne GK, Dean S (1991) A five-year plus follow-up survey of criminal recidivism within a treated cohort of 406 pedophiles, 111 exhibitionists and 109 sexual aggressives: issues and outcome. Am J Forensic Psychiatry 12(3): 5-28
3. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA (1993a) Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262: 578-580
4. Brunner HG, Nelen MR, van Zandvoort P, Abeling NG, van Gennip AH, Wolters EC, Kuiper MA, Ropers HH, van Oost BA (1993b) X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet 52: 1032-1039
5. Buchsbaum MS, Coursey RD, Murphy DL (1976) The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity. Science 194: 339-341
6. Cases O, Self I, Grimsby J, Gaspar P, Chen K, Ournin S, Muller U, Aguet M, Babinet C, Shih JC, De Maeyer E (1995) Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268: 1763-1766
7. Collins FA, Murphy DL, Reiss AL, Sims KB, Lewis JG, Freund L, Karoum F, Zhu D, Maumenee IH, Antonarakis SE (1992) Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp 11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes. Am J Med Genet 42: 127-134
8. Constantino JN, Murphy DL (1996) Monoamine metabolites in "leftover" newborn human cerebrospinal fluid-a potential resource for biobehavioral research. Psychiatry Res 65: 129-142
9. Coursey RD, Buchsbaum MS, Murphy DL (1982) 2-year follow-up of subjects and their families defined as at risk for psychopathology on the basis of platelet MAO activities: 2-year follow-up of low platelet MAO. Neuropsychobiology 8: 51-56
10. Crane GE (1956) Further studies on iproniazid phosphate isonicotinil-isopropylhydrazine phosphate marsilid. J Nerv Ment Dis 124: 322
11. Donnelly CH, Murphy DL (1977) Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase. Biochem Pharmacol 26: 853-858
12. Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL, Kopin IJ (1986) Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 32: 2030-2033
13. Eisenhofer G, Friberg P, Pacak K, Goldstein DS, Murphy DL, Tsigos C, Quyyumi AA, Brunner HG, Lenders JW (1995) Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism? Clin Sci 88: 533-542
14. Eisenhofer G, Aneman A, Hooper D, Rundqvist B, Friberg P (1996) Mesenteric organ production, hepatic metabolism, and renal elimination of norepinephrine and its metabolites in humans. J Neurochem 66: 1565-1573
15. Ernst M, Liebenauer LL, Tebeka D, Jons PH, Eisenhofer G, Murphy DL, Zametkin AJ (1997) Selegiline in ADHD adults plasma monoamines and monoamine metabolites. Neuropsychopharmacology 16: 276-284
16. Fowler CJ, Tipton KF, MacKay AV, Youdim MB (1982) Human platelet monoamine oxidase-a useful enzyme in the study of psychiatric disorders? Neuroscience 7(7): 1577-1594
17. Freymuth HW, Walker H, Baumecker P, Stein H (1959) Effects of iproniazid on chronic and regressed schizophrenics. Dis Nerv Syst 20: 123
18. George DT, Benkelfat C, Rawlings RR, Eckardt MJ, Phillips MJ, Nutt DJ, Wynne D, Murphy DL, Linnoila M (1997) Behavioral and neuroendocrine responses to m-Chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects. Am J Psychiatry 154(1): 81-87
19. Grimsby J, Chen K, Wang L-J, Lan NC, Shih JC (1991) Human monoamine oxidase A and B genes exhibit identical exon-intron organization. Proc Natl Acad Sci 88: 3637-3641
20. Higley JD, Thompson WW, Champoux M, Goldman D, Hasert MF, Kraemer GW, Scanlan JM, Suomi SJ, Linnoila M (1993) Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in rhesus monkeys (macaca mulatta). Arch Gen Psychiatry 50: 615-623
21. Hsu YP, Schuback DE, Tivol EA, Shalish C, Murphy DL, Breakefield XO (1995) Analysis of MAOA mutations in humans. Prog Brain Res 106: 67-75
22. Kopin IJ, Gordon EK, Jimerson DC, Polinsky RJ (1983) Relationship between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxy-phenyl-glycol. Science 219: 73-75
23. Kopin IJ, Blombery P, Ebert MH, Gordon EK, Jimerson DC, Markey SP, Polinsky RJ (1984) Disposition and metabolism of MHPG-CD3 in humans: plasma MHPG as the principal pathway of norepinephrine metabolism and as an important determinant of CSF levels of MHPG. Adv Biochem Psychopharmacol 39: 57-68
24. Lenders JWM, Eisenhofer G, Abeling NGGM, Berger W, Murphy DL, Konings CH, Wagemakers LMB, Kopin IJ, Karoum F, van Gennip AH, Brunner HG (1996) Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. J Clin Invest 97: 1-10
25. Lesch K-P, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527-1531
26. Murphy DL (1977) The behavioral toxicity of monoamine oxidase-inhibiting antidepressants. Adv Pharmacol Chemother 14: 71-105
27. Murphy DL, Wright C, Buchsbaum M, Costa J, Nichols A, Wyatt R (1976) Platelet and plasma amine activities in 650 normals: sex and age differences and stability over time. Biochem Med 16: 254-265
28. Murphy DL, Lipper S, Slater S, Shiling D (1979) Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man. Psychopharmacology 62: 129-132
29. Murphy DL, Pickar D, Jimerson D, Cohen RM, Garrick NA, Karoum F, Wyatt RJ (1981) Biochemical indices of the effects of the selective MAO inhibitors clorgyline, pargyline and deprenyl in man. In: Usdin E, Dahl SG, Gram LF, Ligjaerde O (eds) Clinical pharmacology in psychiatry: neuroleptic and antidepressant research. Macmillan, London, pp 307-316
30. Murphy DL, Sims KB, Karoum F, de la Chapelle A, Norio R, Sankila E-M, Breakefield XO (1990) Marked amine and amine metabolite changes in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase. J Neurochem 54: 242-247
31. Murphy DL, Sims KB, Karoum F, Garrick NA, de la Chapelle A, Sankila EM, Norio R, Breakefield XO (1991) Plasma amine oxidase activities in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase. J Neural Transm [Gen Sect] 83: 1-12
32. Oreland L, Hallman J (1995) The correlation between platelet MAO activity and personality: short review of findings and a discussion on possible mechanisms. Prog Brain Res 106: 77-84
33. Oxenstierna G, Edman G, Iselius L, Oreland L, Ross SB, Sedvall G (1986) Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals: a genetic study. J Psychiatr Res 20: 19-29
34. Plomin R, Owen MJ, McGuffin P (1994) The genetic basis of complex human behaviors. Science 264: 1733-1739
35. Rabkin JG, Quitin FM, McGrath P, Harrison W, Tricamo E (1985) Adverse reactions to monoamine oxidase inhibitors, part II. Treatment correlates and clinical management. J Clin Psychopharmacol 5: 2-9
36. Schalling D, Asberg M, Edman G, Oreland L (1987) Markers for vulnerability to psychopathology: temperament traits associated with platelet MAO activity. Acta Psychiatr Scand 76(2): 172-182
37. Shih JC, Grimsby J, Chen K, Zhu Q (1993) Structure and promoter organization of the human monoamine oxidase A and B genes. J Psychiatry Neurosci 18: 25-32
38. Sims KB, de la Chapelle A, Norio R, Sankila E-M, Hsu Y-PP, Rinehart WB, Corey TJ, Ozelius L, Powell JF, Bruns G, Gusella JF, Murphy DL, Breakefield XO (1989) Monoamine oxidase deficiency in males with an X chromosome deletion. Neuron 2: 1069-1076
39. Sunderland T, Mueller EA, Cohen RM, Jimerson DC, Pickar D, Murphy DL (1985)-Tyramine pressor sensitivity changes during deprenyl treatment. Psychopharmacology 86: 432-437
40. Whitaker-Azmitia PM, Zhang X, Clarke C (1994) Effects of gestational exposure to monoamine oxidase inhibitors in rats: preliminary behavioral and neurochemical studies. Neuropsychopharmacology 11: 125-132